Home » Stocks » MEDS

Trxade Group, Inc. (MEDS)

Stock Price: $4.77 USD 0.01 (0.21%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
Market Cap 38.60M
Revenue (ttm) 17.12M
Net Income (ttm) -2.54M
Shares Out 7.71M
EPS (ttm) -0.33
PE Ratio n/a
Forward PE 21.83
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $4.77
Previous Close $4.76
Change ($) 0.01
Change (%) 0.21%
Day's Open 4.90
Day's Range 4.60 - 4.90
Day's Volume 54,733
52-Week Range 4.02 - 8.25

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

TAMPA, FL / ACCESSWIRE / April 12, 2021 / Trxade Group, Inc. (NASDAQ:MEDS) , a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the presc...

5 days ago - Accesswire

CEO Suren Ajjarapu to Present Wednesday, April 21st, 2021 TAMPA, FL / ACCESSWIRE / April 9, 2021 / Trxade Group, Inc. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharm...

1 week ago - Accesswire

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform

2 weeks ago - GlobeNewsWire

TAMPA, FL / ACCESSWIRE / March 15, 2021 / Trxade Group, Inc. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the pr...

1 month ago - Accesswire

TAMPA, FL / ACCESSWIRE / March 5, 2021 / Trxade Group, Inc. (NASDAQ:MEDS), a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience, today announced t...

1 month ago - Accesswire

TAMPA, FL, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. ( MEDS ) an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the Diamond Equ...

4 months ago - GlobeNewsWire

Trxade Group Inc. (NASDAQ: MEDS) shares jumped on Tuesday after the company announced that it entered into a definitive agreement with Amazon.com Inc.

Other stocks mentioned: AMZN
5 months ago - 24/7 Wall Street

Shares of Trxade Group Inc. soared 56% in active trading to pace all of the premarket's gainers Tuesday, after the online platform for pharmaceutical purchases announced a market program agreement with ...

5 months ago - Market Watch

About MEDS

Trxade Group, Inc., together with its subsidiaries, operates a business-to-business (B2B) web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; Integra Pharma, LLC; and Other segments. The company operates a web-based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a web-based pharmaceutical marketplace; InventoryRx.com, ... [Read more...]

Industry
Pharmaceutical Retailers
IPO Date
Feb 13, 2020
Stock Exchange
NASDAQ
Ticker Symbol
MEDS
Full Company Profile

Financial Performance

In 2020, Trxade Group's revenue was $17.12 million, an increase of 130.26% compared to the previous year's $7.44 million. Losses were -$2.54 million, 791.6% more than in 2019.

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Trxade Group stock is "Buy." The 12-month stock price forecast is 11.50, which is an increase of 141.09% from the latest price.

Price Target
$11.50
(141.09% upside)
Analyst Consensus: Buy